We are still accepting manuscripts for COVID 19 Special Issue “Methods to Facilitate SARS CoV 2 and COVID 19 Research”Posted on 2021-04-11
The novel 2019 coronavirus disease (COVID-19) pandemic has impacted all of us in difficult ways and is affecting millions of people around the globe. It has created a tremendous health burden and unexpected challenges for research. However, rapid detection, tracking, and characterization of the SARS-CoV-2 virus and COVID-19 disease can potentially help mitigate the spread of disease by informing public policy and improving the development of effective therapeutics and vaccines.
Many researchers who never previously investigated coronaviruses have converted their research programs for characterization of SARS-CoV-2 or its infection in COVID-19 patients. This has required co-opting previous laboratory protocols or developing new protocols. To ensure the highest quality research-based response to combat COVID-19, working and tested protocols must be disseminated widely to the research community.
The Journal of Biological Methods (JBM) is pleased to announce a call for papers for an upcoming special issue entitled “Methods to Facilitate SARS-CoV-2 and COVID-19 Research.” This special issue will be guest edited by Dr. Keith T. Gagnon at the Southern Illinois University School of Medicine.
Topics of interest include molecular, clinical, and experimental methods that can broadly facilitate or accelerate SARS-CoV-2 and COVID-19 research. These include molecular, in silico, cellular, and animal model systems of COVID-19 disease, propagation of SARS-CoV-2 in cell culture, isolation of intact SARS-CoV-2 viral particles, methods to purify and characterize SARS-CoV-2 viral proteins, determination or prediction of protein structures, molecular modeling and docking simulations to identify drug candidates, methods for nucleic acid therapeutic development against coronavirus, viral RNA structure prediction and determination, bioinformatics approaches such as phylogenetics or phylogeography, and sequencing of SARS-CoV-2 viral genomes and transcriptomes by various platforms.
We emphasize working protocols for this special issue that may have been published in part in previous reports from prospective authors. However, we encourage all manuscript formats, including Articles, Benchmarks, Protocols, Resources, and Reviews. Please contact Dr. Gagnon (email@example.com) or firstname.lastname@example.org with questions or inquiries about suitability. If your method is accepted for publication, a 20% discount on the Article Processing Charge (APC) will be applied, bringing the total cost of publication down to $800 USD. JBM is a PubMed-indexed journal and all articles are made open access https://www.polscientific.com/jbm.
We look forward to your submission!